Horizon Pharma settles Duexis case with Par Pharmaceuticals

22-08-2013

Horizon Pharma settles Duexis case with Par Pharmaceuticals

US-based Horizon Pharma Inc agreed on August 22 to settle its patent dispute over arthritis drug Duexis with generic maker Par Pharmaceutical Companies.


Horizon, Par, Duexis, settlement

LSIPR